Free Trial
NYSE:SOLV

Solventum (SOLV) Stock Price, News & Analysis

Solventum logo
$73.65 +1.65 (+2.29%)
As of 03:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Solventum Stock (NYSE:SOLV)

Key Stats

Today's Range
$72.01
$74.17
50-Day Range
$70.87
$78.21
52-Week Range
$59.35
$85.92
Volume
582,805 shs
Average Volume
1.08 million shs
Market Capitalization
$12.77 billion
P/E Ratio
34.08
Dividend Yield
N/A
Price Target
$85.75
Consensus Rating
Hold

Company Overview

Solventum Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
35th Percentile Overall Score

SOLV MarketRank™: 

Solventum scored higher than 35% of companies evaluated by MarketBeat, and ranked 756th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Solventum has received a consensus rating of Hold. The company's average rating score is 2.27, and is based on 4 buy ratings, 6 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Solventum has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Solventum's stock forecast and price target.
  • Earnings Growth

    Earnings for Solventum are expected to decrease by -16.57% in the coming year, from $6.58 to $5.49 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Solventum is 34.16, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.38.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Solventum is 34.16, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 30.90.

  • Price to Earnings Growth Ratio

    Solventum has a PEG Ratio of 1.77. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Solventum has a P/B Ratio of 3.51. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Solventum's valuation and earnings.
  • Percentage of Shares Shorted

    2.72% of the float of Solventum has been sold short.
  • Short Interest Ratio / Days to Cover

    Solventum has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Solventum has recently decreased by 2.08%, indicating that investor sentiment is improving.
  • Dividend Yield

    Solventum does not currently pay a dividend.

  • Dividend Growth

    Solventum does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.72% of the float of Solventum has been sold short.
  • Short Interest Ratio / Days to Cover

    Solventum has a short interest ratio ("days to cover") of 4.1.
  • Change versus previous month

    Short interest in Solventum has recently decreased by 2.08%, indicating that investor sentiment is improving.
  • News Sentiment

    Solventum has a news sentiment score of 1.13. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 22 news articles for Solventum this week, compared to 13 articles on an average week.
  • Search Interest

    Only 5 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of -38% compared to the previous 30 days.
  • MarketBeat Follows

    Only 5 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
Receive SOLV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Solventum and its competitors with MarketBeat's FREE daily newsletter.

SOLV Stock News Headlines

"I'm risking my reputation on this"
A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That's why we've rushed to update our book "Crypto Revolution" – to show you exactly how to position yourself for this historic opportunity.tc pixel
Solventum Announces $1.75 Billion Note Tender Offers
Do Wall Street Analysts Like Solventum Stock?
See More Headlines

SOLV Stock Analysis - Frequently Asked Questions

Solventum's stock was trading at $66.06 at the beginning of the year. Since then, SOLV stock has increased by 11.7% and is now trading at $73.8050.

Solventum Corporation (NYSE:SOLV) posted its quarterly earnings results on Thursday, August, 7th. The company reported $1.69 earnings per share for the quarter, topping the consensus estimate of $1.45 by $0.24. Solventum's quarterly revenue was up 3.8% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Solventum include Vanguard Group Inc. (9.39%), Independent Franchise Partners LLP (5.85%), State Street Corp (3.52%) and Davis Selected Advisers (3.17%).

Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Solventum investors own include Chevron (CVX), American Water Works (AWK), The RMR Group (RMR), Bristol Myers Squibb (BMY), DiamondRock Hospitality (DRH), Waste Connections (WCN) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
8/07/2025
Today
8/22/2025
Next Earnings (Estimated)
11/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NYSE:SOLV
Previous Symbol
NYSE:SOLV
CIK
1964738
Fax
N/A
Employees
22,000
Year Founded
N/A

Price Target and Rating

High Price Target
$103.00
Low Price Target
$71.00
Potential Upside/Downside
+19.3%
Consensus Rating
Hold
Rating Score (0-4)
2.27
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.16
Trailing P/E Ratio
33.29
Forward P/E Ratio
10.93
P/E Growth
1.77
Net Income
$478 million
Net Margins
4.52%
Pretax Margin
3.83%
Return on Equity
29.93%
Return on Assets
6.65%

Debt

Debt-to-Equity Ratio
2.14
Current Ratio
1.22
Quick Ratio
0.86

Sales & Book Value

Annual Sales
$8.25 billion
Price / Sales
1.51
Cash Flow
$9.81 per share
Price / Cash Flow
7.33
Book Value
$21.02 per share
Price / Book
3.42

Miscellaneous

Outstanding Shares
173,390,000
Free Float
173,301,000
Market Cap
$12.47 billion
Optionable
Optionable
Beta
0.52

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NYSE:SOLV) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners